Carbon ion radiotherapy: Clinical experiences at national institute of radiological science (NIRS)

Journal of Radiation Research

Volumn 51, Issue 4, 2010, Pages 355-364

  Okada, Tohru ^a   Kamada, Tadashi ^a   Tsuji, Hiroshi ^a   Mizoe, Jun Etsu ^a   Baba, Masayuki ^a   Kato, Shingo ^a   Yamada, Shigeru ^a   Sugahara, Shinji ^a   Yasuda, Shigeo ^a   Yamamoto, Naoyoshi ^a   Imai, Reiko ^a   Hasegawa, Azusa ^a   Imada, Hiroshi ^a   Kiyohara, Hiroki ^a   Jingu, Kenichi ^a   Shinoto, Makoto ^a   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CARBON; DISEASES; IONS; ONCOLOGY; RADIOTHERAPY;

BIOLOGICAL CHARACTERISTIC; CANCER THERAPY; CARBON ION RADIOTHERAPY; CARBON IONS; CLINICAL EXPERIENCE; ION SPECIES; NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES; NORMAL TISSUE; OPTIMAL PROPERTIES; PHYSICAL CHARACTERISTICS;

TUMORS;

EID: 77954971912     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.10016     Document Type: Review

References (49)

1. Wilson RR (1946) Radiological use of fast protons. Radiology 47: 487-491.
2. Linstadt DE, Castro JR and Phillips TL (1991) Neon ion radiotherapy: results of phase I/II clinical trial. Int J Radiat Oncol Biol Phys 20: 761-769.
3. Castro JR (1995) Future research strategy for heavy ion radiotherapy. In: Progress in Radio-Oncology. ed. Kogelnik HD, pp 643-648, Monduzzi Editore, Italy.
4. Tsujii H, et al (2007) Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 48: Suppl, A1-A13.
5. Schulz-Ertner D and Tsujii H (2007) Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25(8): 953-964.
6. Minohara S, et al (2010) Recent innovations in carbon-ion radiotherapy. J Radiat Res 51: 385-392.
7. Raju MR (1980) Heavy particle radiotherapy. Academic Press, New York.
8. Hamada N, et al (2010) Recent advances in the biology of heavy-ion cancer therapy. J Radiat Res 51: 365-383 (doi: 10.1269/jrr.09137).
9. Denekamp J, Waites T and Fowler JF (1997) Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Oncol Biol Phys 71: 681-694.
10. Koike S, et al (2002) Significance of fractionated irradiation for biological therapeutic gain of carbon ion. Radiat Prot Dos 99: 405-408.
11. Ando K, et al (2005) Biological gain of carbon-ion therapy for the early response of skin reaction in mice. J Radiat Res 46: 51-57.
12. Tsujii H (2009) Overview of carbon ion radiotherapy at NIRS. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp3-12, NIRS-M-225.
13. Tsujii H, et al (1997) Preliminary results of phase I/II carbon ion therapy at the NIRS. J Brachytherapy Int 13: 1-8.
14. Tsujii H, et al (2002) Experiences of carbon ion radiotherapy at NIRS. In: Progress in Radio-Oncology VII. ed. Kogelnik HD, pp 393-405, Monduzzi Editore, Italy.
15. Tsujii H, et al (2004) Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 73(Suppl 2): S41-S49.
16. Miyamoto T, et al (2007) Curative treatment of stage I non-small cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 67: 750-758.
17. Miyamoto T, et al (2007) Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thoracic Oncol 10: 916-926.
18. Baba M, et al (2009) Carbon ion radiotherapy in hypofraction regimen for stage I non-small cell lung cancer. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp25-36, NIRS-M-225.
19. Nagata Y, et al (2005) Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using stereotactic body frame. Int J Radiat Oncol Biol Phys 63: 1427-1431.
20. Onishi H, et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2(7 Suppl 3): S94-S100.
21. Timmerman R, et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24: 4833-4839.
22. Kato H, et al (2004) Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59: 1468-1476.
23. Kato H, et al (2004) Four-fraction carbon ion radiotherapy for hepatocellular carcinoma. J Clin Oncol 22(14S), Proceeding of ASCO 2004 Annual Meeting 335s.
24. Kato H, et al (2005) Two-fraction carbon ion radiotherapy for hepatocellular carcinoma: Preliminary results of a phase I/II clinical trial. J Clin Oncol 23(16S), Proceeding of ASCO 2005 Annual Meeting 4124.
25. Imada H, et al (2009) Carbon Ion Therapy for Hepatocellular Carcinoma. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp44-50, NIRS-M-225.
26. Akakura K, et al (2004) Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate 58: 252-258.
27. Tsuji H, et al (2005) Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 63: 1153-1160.
28. Ishikawa H, et al (2006) Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol 81: 57-64.
29. Tsuji H, et al (2009) Carbon ion radiotherapy for prostate cancer. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp75-82, NIRS-M-225.
30. Galandiuk R, et al (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obset 174: 27-32.
31. Bozzetti F, et al (1996) Cancer of the low and middle rectum: local and distant recurrence and survival in 350 radically resected patients. J Surg Oncol 62: 207-213.
32. McCall J, et al (1996) Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 10: 126-132.
33. Yamada S, et al (2009) Carbon ion radiotherapy for patients with locally recurrent rectal cancer. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp51-58, NIRS-M-225.
34. Yamada S and Ando K (2002) Combination of chemotherapy and heavy-ion particle therapy for pancreas cancer. Annual report of the research project with heavy ion at NIRS-HIMAC 174-175.
35. Yamada S, et al (2009) Pancreas cancer. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp59-66, NIRS-M-225.
36. Nakano T, et al (1999) The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix. Cancer J Sci Am 5: 362-369.
37. Kato S, et al (2006) Dose escalation study of carbon ion radiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 65: 388-397.
38. Nakano T, et al (2006) Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res 12(7): 2185-2190.
39. Kato S, et al (2009) Carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp67-74, NIRS-M-225.
40. Mizoe J-E, et al (2004) Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 60: 358-364.
41. Hasegawa A, et al (2006) Outcomes of visual acuity in carbon ion radiotherapy: Analysis of dose-volume histograms and prognostic factors. Int J Radiat Oncol Biol Phys 64: 396-401.
42. Jingu K, et al (2009) Head and neck tumors. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp18-24, NIRS-M-225.
43. Kamada T, et al (2002) Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 20: 4466-4471.
44. Imai R, et al (2004) Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 10(17): 5741-5746.
45. Imai R, et al (2006) Cervical spine osteosarcoma treated with carbon ion radiotherapy. Lancet Oncol 7: 1034-1035.
46. Kamada T, et al (2008) Carbon ion radiotherapy for bone and soft tissue sarcomas. J Clin Oncol 26(15S) 2008 ASCO Annual Meeting Proceedings 10538.
47. Tsuji H, et al (2007) Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 67: 857-862.
48. Hirasawa N, et al (2007) Risk factors for neovascular glaucoma after carbon ion therapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 67: 538-543.
49. Kamada T and Tsujii H (2009) Carbon ion therapy: clinical study. Proceedings of NIRS-IMP Joint Symposium on Carbon Ion Therapy. pp84-86, NIRS-M-225.